Conclusions: This study elucidates an important mechanism by which myeloma-induced bone lesions, suggesting that hnRNPA2B1 may be targeted to prevent myeloma-associated bone disease. The gene discussed is HNRNPA2B1; the disease is plasma cell myeloma.